295 related articles for article (PubMed ID: 26441160)
1. Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis.
Yang L; Xie S; Feng X; Chen Y; Zheng T; Dai M; Zhou CK; Hu Z; Li N; Hang D
Sci Rep; 2015 Oct; 5():14667. PubMed ID: 26441160
[TBL] [Abstract][Full Text] [Related]
2. Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis.
Moghoofei M; Keshavarz M; Ghorbani S; Babaei F; Nahand JS; Tavakoli A; Mortazavi HS; Marjani A; Mostafaei S; Monavari SH
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e59-e67. PubMed ID: 30740893
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and bladder cancer risk: a meta-analysis.
Li N; Yang L; Zhang Y; Zhao P; Zheng T; Dai M
J Infect Dis; 2011 Jul; 204(2):217-23. PubMed ID: 21673031
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
Adami HO; Kuper H; Andersson SO; Bergström R; Dillner J
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):872-5. PubMed ID: 14504197
[TBL] [Abstract][Full Text] [Related]
5. HPV persistence and its oncogenic role in prostate tumors.
Tachezy R; Hrbacek J; Heracek J; Salakova M; Smahelova J; Ludvikova V; Svec A; Urban M; Hamsikova E
J Med Virol; 2012 Oct; 84(10):1636-45. PubMed ID: 22930513
[TBL] [Abstract][Full Text] [Related]
6. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer.
Tu H; Jacobs SC; Mergner WJ; Kyprianou N
Urology; 1994 Nov; 44(5):726-31. PubMed ID: 7974946
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.
Lin Y; Mao Q; Zheng X; Yang K; Chen H; Zhou C; Xie L
Ir J Med Sci; 2011 Jun; 180(2):497-503. PubMed ID: 21400096
[TBL] [Abstract][Full Text] [Related]
8. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies.
Carozzi F; Lombardi FC; Zendron P; Confortini M; Sani C; Bisanzi S; Pontenani G; Ciatto S
Int J Biol Markers; 2004; 19(4):257-61. PubMed ID: 15646830
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Sutcliffe S; Viscidi RP; Till C; Goodman PJ; Hoque AM; Hsing AW; Thompson IM; Zenilman JM; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):614-8. PubMed ID: 20142255
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection and colorectal cancer risk: a meta-analysis.
Damin DC; Ziegelmann PK; Damin AP
Colorectal Dis; 2013 Aug; 15(8):e420-8. PubMed ID: 23895733
[TBL] [Abstract][Full Text] [Related]
11. Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population--a pioneering case-control analysis.
Singh N; Hussain S; Kakkar N; Singh SK; Sobti RC; Bharadwaj M
Sci Rep; 2015 Jan; 5():7822. PubMed ID: 25592643
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2952-5. PubMed ID: 16365015
[TBL] [Abstract][Full Text] [Related]
13. The role of human papillomavirus infection in prostate carcinoma.
Aghakhani A; Hamkar R; Parvin M; Ghavami N; Nadri M; Pakfetrat A; Banifazl M; Eslamifar A; Izadi N; Jam S; Ramezani A
Scand J Infect Dis; 2011 Jan; 43(1):64-9. PubMed ID: 20662618
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males.
Wideroff L; Schottenfeld D; Carey TE; Beals T; Fu G; Sakr W; Sarkar F; Schork A; Grossman HB; Shaw MW
Prostate; 1996 Feb; 28(2):117-23. PubMed ID: 8604392
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis.
Li N; Bi X; Zhang Y; Zhao P; Zheng T; Dai M
Breast Cancer Res Treat; 2011 Apr; 126(2):515-20. PubMed ID: 20740311
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis.
Russo GI; Calogero AE; Condorelli RA; Scalia G; Morgia G; La Vignera S
Aging Male; 2020 Jun; 23(2):132-138. PubMed ID: 29571270
[No Abstract] [Full Text] [Related]
17. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis.
Olesen TB; Svahn MF; Faber MT; Duun-Henriksen AK; Junge J; Norrild B; Kjaer SK
Gynecol Oncol; 2014 Jul; 134(1):206-15. PubMed ID: 24607284
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Type Distribution of Human Papilloma Virus in Patients with Prostate Cancer, Kerman, Southeast of Iran.
Atashafrooz F; Rokhbakhsh-Zamin F
Asian Pac J Cancer Prev; 2016; 17(8):3953-8. PubMed ID: 27644644
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and prostate cancer: systematic review and meta-analysis.
Tsydenova IA; Ibragimova MK; Tsyganov MM; Litviakov NV
Sci Rep; 2023 Oct; 13(1):16597. PubMed ID: 37789036
[TBL] [Abstract][Full Text] [Related]
20. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
Michopoulou V; Derdas SP; Symvoulakis E; Mourmouras N; Nomikos A; Delakas D; Sourvinos G; Spandidos DA
Tumour Biol; 2014 Dec; 35(12):12765-73. PubMed ID: 25213701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
